1-12 of 12
Andreas Buck
Close
Sort by
Journal Articles

Functional Imaging As a Key Diagnostic Tool in the Follow-up of RRMM Patients after CAR-T-Cell Therapy

Sven Schimanski, Hannah Hornburger, Sofie-Katrin Kadel, Anna Marie Ruckdeschel, Florian Eisele, Daniela Schneider, Anke Heidemeier, Andreas Buck, Rudolf Werner, Johannes M Waldschmidt, Paula Tabares, Andreas Beilhack, Johannes Duell, Hermann Einsele, K. Martin Kortüm, Max S. Topp, Leo Rasche
Journal: Blood
Blood (2023) 142 (Supplement 1): 3372.
https://doi.org/10.1182/blood-2023-188501
Published: 2023
Journal Articles

Pseudoprogression and Sarcoidosis-like Phenomena after CART-Cells and Bispecific Antibodies in Multiple Myeloma

Alexander Leipold, Rudolf Werner, Johannes Duell, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Andreas Buck, Julia Mersi, Hermann Einsele, K. Martin Kortuem, Antoine-Emmanuel Saliba, Leo Rasche
Journal: Blood
Blood (2022) 140 (Supplement 1): 10020–10021.
https://doi.org/10.1182/blood-2022-168836
Published: 2022
Journal Articles

Real-World Experience with Minimal Residual Disease Testing with Next Generation Flow Cytometry and Functional Imaging in Multiple Myeloma

David Böckle, MD, Paula Tabares Gaviria, Xiang Zhou, MD, Janin Messerschmidt, MD, Lukas Scheller, Maximilian Johannes Steinhardt, MD, Elena Seebacher, Maria Ulbrich, Anke Heidemeier, MD, Andreas Buck, MD, Hermann Einsele, MD, Andreas Beilhack, MD, Martin Kortuem, MD, Leo Rasche, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-140772
Published: 2020
Journal Articles

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

Peter Herhaus, MD, Jana Lipkova, Felicitas Lammer, MD, Julia Slotta-Huspenina, MD, Benedikt Wiestler, MD, Tibor Vag, MD, Stefan Habringer, MD, Igor Yakushev, MD, Constantin Lapa, MD, Tobias Pukrop, MD, Dirk Hellwig, MD, Andreas Buck, MD, Martina Deckert, MD, Hans-Jürgen Wester, PhD, Florian Bassermann, MD PhD, Wolfgang Weber, MD, Markus Schwaiger, MD, Björn Menze, PhD, Ulrich Keller, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2900.
https://doi.org/10.1182/blood-2019-126024
Published: 2019
Journal Articles

CXCR4 PET/CT Scan Is Superior to FDG PET/CT Scan in Accurately Defining Marginal Zone Lymphoma Nodal and Extranodal Involvement

Johannes Duell, MD, Andreas Rosenwald, Franziska Krummenast, MD, Andreas Buck, MD, Hermann Einsele, MD, Max S. Topp, Constantin Lapa, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2881.
https://doi.org/10.1182/blood-2018-99-118339
Published: 2018
Journal Articles

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

Kathrin Philipp-Abbrederis, Ken Herrmann, Margret Schottelius, Matthias Eiber, Carlos Gerngroß, Elke Pietschmann, Katharina Lückerath, Katharina Franke, Martina Rudelius, MD, Stefan Knop, MD, Katharina Götze, Kristina Schwamborn, Sabine Steidle, MD, Ambros Beer, Christian Peschel, Hermann Einsele, Andreas Buck, Markus Schwaiger, Hans-Jürgen Wester, Ulrich Keller, MD
Journal: Blood
Blood (2014) 124 (21): 2014.
https://doi.org/10.1182/blood.V124.21.2014.2014
Published: 2014
Journal Articles

[18F]FLT Is Superior to [18F]FDG to Early Predict Response to Specific Inhibitors of NPM-ALK-Dependent Pathways In a Human ALCL Xenograft Model

Nicolas Graf, MD, Zhoulei Li, Ken Herrmann, MD, Alexandra Junger, Daniel Weh, Christian Peschel, MD, Markus Schwaiger, MD, Andreas Buck, MD, Tobias Dechow, MD
Journal: Blood
Blood (2010) 116 (21): 2849.
https://doi.org/10.1182/blood.V116.21.2849.2849
Published: 2010
Journal Articles

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

Jürgen den Hollander, Sara Rimpi, Joanne R. Doherty, Martina Rudelius, Andreas Buck, Alexander Hoellein, Marcus Kremer, Nikolas Graf, Markus Scheerer, Mark A. Hall, Andrei Goga, Nikolas von Bubnoff, Justus Duyster, Christian Peschel, John L. Cleveland, Jonas A. Nilsson, Ulrich Keller
Journal: Blood
Blood (2010) 116 (9): 1498–1505.
https://doi.org/10.1182/blood-2009-11-251074
Published: 2010
Includes: Supplemental data
Journal Articles

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Jan Dörr, Yong Yu, Christoph Loddenkemper, MD, PhD, Ulrich Keller, MD, Andreas Buck, Bernd Dörken, Clemens Schmitt, MD
Journal: Blood
Blood (2009) 114 (22): 1686.
https://doi.org/10.1182/blood.V114.22.1686.1686
Published: 2009
Journal Articles

Antifungal Therapy with Itraconazole Impairs Rituximab′s Anti-Lymphoma Effect by Inhibiting CD20 Recruitment to Lipid Rafts.

Christian Meyer zum Bueschenfelde, Yvonne Feuerstacke, Philipp Krainz, Ken Herrmann, Andreas Buck, Christian Peschel, MD, Ingo Ringshausen
Journal: Blood
Blood (2009) 114 (22): 2735.
https://doi.org/10.1182/blood.V114.22.2735.2735
Published: 2009
Journal Articles

Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.

Malik E. Juweid, MD, Sergei I. Syrbu, Michelle Bleile, Andreas Buck, Marielle Wondergem, MD, Julie M. Vose, M.D.
Journal: Blood
Blood (2009) 114 (22): 3236.
https://doi.org/10.1182/blood.V114.22.3236.3236
Published: 2009
Journal Articles

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Clinical Trials & Observations
Donald Bunjes, Inga Buchmann, Christian Duncker, Ulrike Seitz, Jörg Kotzerke, Markus Wiesneth, Dagmar Dohr, Martin Stefanic, Andreas Buck, Stefanie V. Harsdorf, Gerhard Glatting, Wolfgang Grimminger, Tunca Karakas, Gerd Munzert, Hartmut Döhner, Lothar Bergmann, Sven N. Reske
Journal: Blood
Blood (2001) 98 (3): 565–572.
https://doi.org/10.1182/blood.V98.3.565
Published: 2001